# FDA Inspection 838912 - SkyePharma Production SAS - May 31, 2013

Source: https://www.keypedia.com/records/fda_inspections/skyepharma-production-sas/cc0dde1d-85bd-495c-9da0-5f946ecac2d6
Source feed: FDA_Inspections

> FDA Inspection 838912 for SkyePharma Production SAS on May 31, 2013. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 838912
- Company Name: SkyePharma Production SAS
- Inspection Date: 2013-05-31
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1265624 - 2023-10-27](https://www.keypedia.com/records/fda_inspections/skyepharma-production-sas/ade17c60-336d-4c76-a263-124b2b0dec6c)
- [FDA Inspection 1105498 - 2019-09-06](https://www.keypedia.com/records/fda_inspections/skyepharma-production-sas/16a39e59-cb2b-4370-9690-8dd1e702f2bf)
- [FDA Inspection 938881 - 2015-06-19](https://www.keypedia.com/records/fda_inspections/skyepharma-production-sas/e84d7610-372f-43cb-8c17-1d3b782f3b1d)
- [FDA Inspection 659061 - 2010-04-02](https://www.keypedia.com/records/fda_inspections/skyepharma-production-sas/c43f2c75-4022-4cfa-bb1e-6fd205981955)

Company: https://www.keypedia.com/companies/skyepharma-production-sas/e27f2a12-7178-49cb-9ef2-08751d66ffcb

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c